| ABOUT BAYBIOGET INVOLVEDEVENT CENTER
MEMBER CENTERINFORMATION CENTERMEDIA CENTERCAREER CENTER |
Adaptive Clinical Trial Design and Implementation Patients, physicians and clinical resources are precious assets to a clinical trial, and it is vital the sponsoring company maximize these assets. To improve clinical research process efficiency and results, the FDA in 2004 proposed The Critical Path Initiative advocating greater use of innovative methods and technologies. The FDA identified adaptive trial designs, e-clinical technologies and biomarker development as key to counter increasingly poor clinical success rates across the industry. Today, these innovations are becoming commonplace within bigger pharma, but how can biotechs and specialty developers take full advantage of these new study approaches? How can you be certain that your clinical strategy is the best one – the strategy with the highest probability of success? Join our panel from small and medium sized companies to discuss real-life experiences for a better understanding of the latest approaches and tools to better guide both study design and execution - even for those on a most cost-conscious budget.
Please mail your event-related questions to: events@baybio.org or you can contact us via phone: 650-871-7101. Is your company a member? Click here to check. |
|||||||||||||||||||||||||||||||